Urapidil
Urapidil is a pharmaceutical drug with 7 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage
Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)
Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
Clinical Trials (7)
Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage
Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)
Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
Effect of High vs. Low MAP Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7